Karen Akinsanya sold $18k of SDGR
See Remarks at Schrodinger, Inc.. 1,366 shares at an average of $12.90, traded Mar 5, 2026, filed Mar 6, 2026.
Score components
- +15RoleOfficer
- 0Trade size$18k at market
- 0Share of holdings soldSold 1.9% of holdings
- +15Cluster5 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001797672-26-000002, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 5, 2026 | SOpen-market sale Common Stock10b5-1 | -1,366 | $12.90 | $18k | 69,956 | Mar 6, 2026 |
Related signals
Other insiders at Schrodinger, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 14Weak | Schrodinger, Inc. | Karen Akinsanya See Remarks | $928k 31,599 shares | -31% | |
| 10Weak | Schrodinger, Inc. | Robert Lorne Abel See Remarks | $17k 1,300 shares | -2% | |
| 26Weak | Schrodinger, Inc. | Ramy Farid President & CEO | $47k 3,661 shares | -1% | |
| 10Weak | Schrodinger, Inc. | Jenny Herman CAO | $18k 1,383 shares | -4% | |
| 17Weak | Schrodinger, Inc. | Rachit Jain EVP & CFO | $21k 1,631 shares | -3% | |
| 15Weak | Schrodinger, Inc. | Karen Akinsanya See Remarks | $26k 2,206 shares | -3% | |
| 28Weak | Schrodinger, Inc. | Ramy Farid President & CEO | $66k 5,560 shares | -2% | |
| 3Weak | Schrodinger, Inc. | Jenny Herman CAO | $10k 752 shares | -3% | |
| 3Weak | Schrodinger, Inc. | Robert Lorne Abel See Remarks | $17k 1,230 shares | -6% | |
| 0Weak | Schrodinger, Inc. | Margaret Dugan Chief Medical Officer | $29k 1,395 shares | -5% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.